A Meta-Analysis of Mid-Term Outcomes of Endovascular Aneurysm Sealing.

George N Kouvelos Petroula NanaA BrodisKonstantinos Spanos Panagiotis T TasoudisA KatsargyrisEric L G Verhoeven

Published in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2022)

Patients who have been treated with EVAS are in high risk for reintervention especially beyond 2 years following implantation. Close surveillance for patients treated with EVAS is mandatory.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
public health
coronary artery
prognostic factors
peritoneal dialysis
metabolic syndrome
adipose tissue
skeletal muscle
insulin resistance
patient reported
glycemic control